Document is current
Any future updates will be listed below
-
Authors
Carrizo, Gustavo E.
Lin, Pianpian
Lee, Seung Hyun
Shenderov, Kevin
Blériot, Camille https://orcid.org/0000-0002-4298-2888
Cha, Minsun
Schimmelpfennig, Lena
Shen, Zhen https://orcid.org/0009-0003-9763-5255
van Teijlingen Bakker, Nikki
Grzes, Katarzyna M.
Kelly, Beth
Safinia, Niloufar
Schole, Kate L.
Musa, Yaarub
Mittler, Gerhard https://orcid.org/0000-0003-2634-0487
Zen, Yoh
Pearce, Edward J.
Ginhoux, Florent
Sanin, David E. https://orcid.org/0000-0003-0188-7267
Puleston, Daniel J. https://orcid.org/0000-0002-8437-0732
Pearce, Erika L. https://orcid.org/0000-0001-5592-5439
- License Information
-
More Information
Article History
Received: 27 May 2024
Accepted: 28 November 2025
First Online: 21 January 2026
Competing interests
: E.L.P. is a SAB member of ImmunoMet Therapeutics and Cour Therapeutics, and E.L.P. and E.J.P. are Scientific Advisors to Remedy Plan Therapeutics.
